Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum Mar 3, 2026 07:30AM
KeyBanc Downgrades Harvard Bioscience Inc. (HBIO) to Sector Weight Apr 9, 2025 02:10AM
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 Mar 12, 2025 04:00PM
KeyBanc Reiterates Overweight Rating on Harvard Bioscience Inc. (HBIO) Aug 8, 2024 03:09PM
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference Mar 11, 2024 08:00AM


Mar 11, 2024 08:00AM Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
Mar 16, 2023 09:25AM Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
Mar 16, 2023 09:25AM Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
May 6, 2021 12:53PM Harvard Bioscience Inc. (HBIO) PT Raised to $10 at KeyBanc
Mar 10, 2021 01:51PM Harvard Bioscience Inc. (HBIO) PT Raised to $9 at KeyBanc